Legal Opinion
Byrd v. Janssen Pharm., Inc.
District Court, N.D. New York
Decided September 21, 2018No. 1:14-CV-0820 (GTS/DJS)PublishedCited by 3 opinions
1Opinion of the Court
GLENN T. SUDDABY, Chief United States District Judge
Currently before the Court, in this products liability action filed by Shaquil Byrd ("Plaintiff") against Janssen Pharmaceuticals, Inc. ("Janssen"), and Johnson & Johnson ("Defendants"), is Defendants' motion for judgment as a matter of law pursuant to Fed. R. Civ. P. 50 or, in the alternative, for a new trial pursuant to Fed. R. Civ. P. 59. (Dkt. No. 199.) For the reasons set forth below, Defendants' motion is granted.
TABLE OF CONTENTS
I. RELEVANT BACKGROUND ...115
A. Relevant Procedural History ...115
B. Parties' Briefing on Defendants'…
2Cases cited41 opinions
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- Exxon Shipping Co. v. BakerSupreme Court of the United States · 2008
- Wyeth v. LevineSupreme Court of the United States · 2009
- Buckman Co. v. Plaintiffs' Legal CommitteeSupreme Court of the United States · 2001
- Lore v. City of SyracuseCourt of Appeals for the Second Circuit · 2012
36 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Holley v. Gilead Scis., Inc.District Court, N.D. California · 2019
- (PS) Cleveland v. Janssen PharmaceuticalsDistrict Court, E.D. California · 2019
- Lancaster v. Ethicon, Inc.District Court, N.D. New York · 2020